GoodRx Holdings (GDRX) Tax Provisions (2019 - 2026)

GoodRx Holdings' Tax Provisions history runs 8 years deep, the most recent figure standing at $4.5 million for Q1 2026.

• In Q1 2026, Tax Provisions fell 20.41% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $25.0 million (up 28.73% YoY), while the FY2025 annual figure was $26.1 million, up 73.19% from the prior year.
• Tax Provisions came in at $4.5 million for Q1 2026 at GoodRx Holdings, down from $8.8 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $19.5 million in Q3 2022 to a low of -$46.7 million in Q2 2023.
• A 5-year average of $501882.4 and a median of $4.5 million in 2026 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions plunged 434.29% in 2023 and jumped 331.34% in 2025, its largest moves.
• GoodRx Holdings' Tax Provisions stood at -$2.8 million in 2022, then jumped by 144.5% to $1.2 million in 2023, then surged by 278.36% to $4.7 million in 2024, then jumped by 87.79% to $8.8 million in 2025, then tumbled by 49.02% to $4.5 million in 2026.
• According to Business Quant data, Tax Provisions over the past three periods registered $4.5 million, $8.8 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison